These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 11825103

  • 1. Is attention deficit hyperactivity disorder increasing among girls in the US? Trends in diagnosis and the prescribing of stimulants.
    Robison LM, Skaer TL, Sclar DA, Galin RS.
    CNS Drugs; 2002; 16(2):129-37. PubMed ID: 11825103
    [Abstract] [Full Text] [Related]

  • 2. National trends in the prevalence of attention-deficit/hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990-1995.
    Robison LM, Sclar DA, Skaer TL, Galin RS.
    Clin Pediatr (Phila); 1999 Apr; 38(4):209-17. PubMed ID: 10326176
    [Abstract] [Full Text] [Related]

  • 3. Physician Office Visits for Attention-deficit/Hyperactivity Disorder in Children and Adolescents Aged 4-17 Years: United States, 2012-2013.
    Albert M, Rui P, Ashman JJ.
    NCHS Data Brief; 2017 Jan; (269):1-8. PubMed ID: 28135186
    [Abstract] [Full Text] [Related]

  • 4. Treatment modalities among US children diagnosed with attention-deficit hyperactivity disorder: 1995-99.
    Robison LM, Sclar DA, Skaer TL, Galin RS.
    Int Clin Psychopharmacol; 2004 Jan; 19(1):17-22. PubMed ID: 15101565
    [Abstract] [Full Text] [Related]

  • 5. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS, Genel M, Bezman RJ, Slanetz PJ.
    JAMA; 1998 Apr 08; 279(14):1100-7. PubMed ID: 9546570
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care.
    McCarthy S, Wilton L, Murray ML, Hodgkins P, Asherson P, Wong IC.
    BMC Pediatr; 2012 Jun 19; 12():78. PubMed ID: 22712630
    [Abstract] [Full Text] [Related]

  • 8. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM, Earls MF.
    Pediatrics; 2005 Jan 19; 115(1):e97-104. PubMed ID: 15629972
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Patterns of psychostimulant prescribing to children with ADHD in Western Australia: variations in age, gender, medication type and dose prescribed.
    Preen DB, Calver J, Sanfilippo FM, Bulsara M, Holman CD.
    Aust N Z J Public Health; 2007 Apr 19; 31(2):120-6. PubMed ID: 17461001
    [Abstract] [Full Text] [Related]

  • 12. National trends in the treatment of attention deficit hyperactivity disorder.
    Olfson M, Gameroff MJ, Marcus SC, Jensen PS.
    Am J Psychiatry; 2003 Jun 19; 160(6):1071-7. PubMed ID: 12777264
    [Abstract] [Full Text] [Related]

  • 13. Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases.
    Raman SR, Man KKC, Bahmanyar S, Berard A, Bilder S, Boukhris T, Bushnell G, Crystal S, Furu K, KaoYang YH, Karlstad Ø, Kieler H, Kubota K, Lai EC, Martikainen JE, Maura G, Moore N, Montero D, Nakamura H, Neumann A, Pate V, Pottegård A, Pratt NL, Roughead EE, Macias Saint-Gerons D, Stürmer T, Su CC, Zoega H, Sturkenbroom MCJM, Chan EW, Coghill D, Ip P, Wong ICK.
    Lancet Psychiatry; 2018 Oct 19; 5(10):824-835. PubMed ID: 30220514
    [Abstract] [Full Text] [Related]

  • 14. Patient and provider characteristics related with prescribing of ADHD medication: Nationwide health insurance claims database study in Korea.
    Song I, Lee MS, Lee EK, Shin JY.
    Asia Pac Psychiatry; 2018 Mar 19; 10(1):. PubMed ID: 28631372
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Physician perceptions of the use of medications for attention deficit hyperactivity disorder.
    Stockl KM, Hughes TE, Jarrar MA, Secnik K, Perwien AR.
    J Manag Care Pharm; 2003 Mar 19; 9(5):416-23. PubMed ID: 14613439
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Current pharmacotherapy of attention deficit hyperactivity disorder.
    Reddy DS.
    Drugs Today (Barc); 2013 Oct 19; 49(10):647-65. PubMed ID: 24191257
    [Abstract] [Full Text] [Related]

  • 19. Gender Differences in the Behavioral Symptoms and Neuropsychological Performance of Patients with Attention-Deficit/Hyperactivity Disorder Treated with Methylphenidate: A Two-Year Follow-up Study.
    Wang LJ, Chen CK, Huang YS.
    J Child Adolesc Psychopharmacol; 2015 Aug 19; 25(6):501-8. PubMed ID: 26262904
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.